PrediMed

Company Overview

Snapshot

Founded in February 2022 by Asaf Harel, Yael Derdikman Ofir, Eddie Garber, and Shaked Ron, PrediMed operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on clinical trials and collaborations with leading institutions to advance its AI-based clinical decision support system.

Business overview

PrediMed develops AI-based tools aimed at enhancing healthcare, with a primary focus on improving MRI scans for children. Its flagship product is an AI-driven clinical decision support system designed to personalize the MRI experience for pediatric patients, matching their needs with local aids to increase the success rate of sedation-free scans. This technology serves the healthcare industry, specifically hospitals and medical providers, by leveraging artificial intelligence and deep learning within the Digital Healthcare and Medical Decision Support sectors.

Company Intelligence Q&A

What is PrediMed's primary focus?

PrediMed is focused on developing AI-based tools to improve healthcare, particularly an AI-based clinical decision support system for pediatric MRI scans.

When was PrediMed founded?

PrediMed was founded in February 2022.

Who are the founders of PrediMed?

PrediMed was founded by Asaf Harel, Yael Derdikman Ofir, Eddie Garber, and Shaked Ron.

What problem does PrediMed's technology address?

PrediMed's system addresses the challenge of keeping children still during MRI scans, aiming to reduce the need for sedation or general anesthesia by personalizing the procedure.

What is the current status of PrediMed's operations?

PrediMed is currently conducting clinical trials and establishing collaborations with leading clinical institutions worldwide to advance its innovative solution. The company ceased to operate in August 2025.